PharmaShots | Incisive News in 3 Shots

Subscribe Now

Editas Medicine

Editas Medicine to Highlight the P-I/II/III (RUBY) Study Data of Reni-Cel for Treating Sickle Cell Disease at EHA 2024

Editas Medicine to Highlight the P-I/II/III (RUBY) Study Data of Reni-Cel for Treating Sickle Cell Disease at EHA 2024

June 14, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us